Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VDPHL01 in male androgenetic alopecia
NCT06972264Phase 3Active, not recruiting
- Sponsor
- Veradermics
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VDPHL01 in androgenetic alopecia (AGA), sponsored by Veradermics. Started Mar 2025; status: active, not recruiting.
02
Drugs
VDPHL01
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06972264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972264.